Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06560346

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia (EARLY-FA); Evaluating New Clinical Outcome Assessments in Children With Friedreich Ataxia to Facilitate Clinical Trial Design.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Friedreich's Ataxia Research Alliance · Academic / Other
Sex
All
Age
4 Years – 21 Years
Healthy volunteers
Accepted

Summary

Multicenter, prospective, observational natural history and outcome measure study of children and young adults with Friedreich ataxia.

Detailed description

A multicenter, prospective, observational natural history and outcome measure study of children and young adults with Friedreich ataxia to further understand the disease features and progression and inform and enable future clinical trials in children with FA. The study, Understanding the natural history early in the presentation of Friedreich ataxia: evaluating new clinical outcome assessments in children with Friedreich ataxia to facilitate clinical trial design (EARLY-FA), evaluates disease features specific to children and novel biomarkers and outcome measures which leveraging existing clinical research infrastructure and data collection from an established natural history study, UNIFAI.

Conditions

Interventions

TypeNameDescription
OTHERGeneticlly confirmed disease causing FXN mutatuionNo intervention in this observational Natural History Study
OTHERHealthy ControlNo intervention in this observational Natural History Study

Timeline

Start date
2025-05-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2024-08-19
Last updated
2025-06-08

Locations

7 sites across 5 countries: United States, Australia, Canada, Germany, Italy

Source: ClinicalTrials.gov record NCT06560346. Inclusion in this directory is not an endorsement.